Loading...
Treating non-responders: pitfalls and implications for cancer immunotherapy trial design
BACKGROUND: Conventional trial design and analysis strategies fail to address the typical challenge of immune-oncology (IO) studies: only a limited percentage of treated patients respond to the experimental treatment. Treating non-responders, we hypothesize, would in part drive non-proportional haza...
Na minha lista:
| Udgivet i: | J Hematol Oncol |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7071722/ https://ncbi.nlm.nih.gov/pubmed/32171307 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-020-0847-x |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|